Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Revance Therapeutics Inc shares valued at $9,096 were sold by Jordan Erica on Apr 16 ’24. At $3.80 per share, Jordan Erica sold 2,392 shares. The insider’s holdings dropped to 114,864 shares worth approximately $0.43 million following the completion of this transaction.
Also, Schilke Tobin sold 9,361 shares, netting a total of over 47,204 in proceeds. Following the sale of shares at $5.04 each, the insider now holds 192,666 shares.
Before that, Sjuts Dustin S had sold 9,211 shares from its account. In a trade valued at $46,446, the President traded Revance Therapeutics Inc shares for $5.04 each. Upon closing the transaction, the insider’s holdings decreased to 9,211 shares, worth approximately $0.63 million.
As published in a research note from Mizuho on January 29, 2024, Revance Therapeutics Inc [RVNC] has been rated down from a Buy to a Neutral and the price target has been revised to $9 from $16. Analysts at Goldman downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early January. As of August 16, 2023, Exane BNP Paribas has increased its “an Underperform” rating to a “Neutral” for RVNC. Earlier on October 11, 2022, Morgan Stanley initiated its rating. Their recommendation was “an Equal-weight” for RVNC stock.
Analyzing RVNC Stock Performance
During the last five days, there has been a drop of approximately -14.74%. Over the course of the year, Revance Therapeutics Inc shares have dropped approximately -57.22%. Shares of the company reached a 52-week high of $9.74 on 01/02/24 and a 52-week low of $3.72 on 04/16/24. A 50-day SMA is recorded $5.28, while a 200-day SMA reached $10.72. Nevertheless, trading volume fell to 1.74 million shares from 2.12 million shares the previous day.
Support And Resistance Levels for Revance Therapeutics Inc (RVNC)
According to the 24-hour chart, there is a support level at 3.70, which, if violated, would cause prices to drop to 3.64. In the upper region, resistance lies at 3.86. The next price resistance is at 3.96. RSI (Relative Strength Index) is 29.13 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.52, which suggests the price will decrease in the coming days. Percent R is at 96.95%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
